Conditional drug approvals set to expand biotech universe

Weighing up risk vs reward

clock • 4 min read

Crises are well-known for accelerating change, and the Covid-19 pandemic was no exception.

Had the delivery of vaccines and therapies not been urgently fast-tracked, countless more lives could have been lost. Conditional drug approvals were key to the rapid pandemic response, and their success is now opening the door to greater utilisation of this life-saving process. While the Covid-19 crisis raised awareness of the accelerated route to drug approval, it is nothing new. In the interest of public health, conditional approvals allow a drug company to legally sell a drug before it meets the comprehensive clinical data normally required. This mechanism was introduced in the 1980s...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Technology

M&G expands thematic offering with global equity AI fund launch

M&G expands thematic offering with global equity AI fund launch

£20m initial investment

Cristian Angeloni
clock 22 January 2024 • 2 min read
CCLA's Helen Luong: How AI might affect your stock picks

CCLA's Helen Luong: How AI might affect your stock picks

Business model disruption

Helen Luong
clock 19 January 2024 • 4 min read
Allfunds launches analysis tool with wealth platform Ardan

Allfunds launches analysis tool with wealth platform Ardan

190,000 funds

Elliot Gulliver-Needham
clock 18 December 2023 • 1 min read
Trustpilot